Top Markets
#1 Siacoin Siacoin +12.95%
#2 Cash Cat Cash Cat +10.66%
#3 0G 0G +8.47%
#4 Arbitrum Arbitrum +6.98%
#5 MarsCoin MarsCoin +6.72%
#6 Seeker Seeker +6.47%
#7 Metis Metis +5.66%
#8 Useless Coin Useless Coin +4.46%
#9 UnifAI Network UnifAI Network +4.42%
#10 Story Story +4.27%
Coin of the day
Siacoin Siacoin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Classificação em ações #14111
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Preço da ação
$1.46
Última sincronização: 2026-07-28
Valor de mercado
$435.25M
Variação (1 dia)
-2.34%
Variação (1 ano)
-25.65%
País
TW
Negociar EirGenix Inc. (6589)

Categoria

Healthcare
Histórico de preços das ações de EirGenix Inc. (6589)
Preço de fecho mais alto: $1.51 em 2026-07-01

Preço de fecho mais baixo: $1.20 em 2016-11-01
Histórico de preços das ações da EirGenix Inc. de 2016 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -13.78%
2025 -9.30%
2024 -26.56%
2023 -26.09%
2022 8.79%
2021 147.12%
2020 94.40%
2019 -9.39%
2018 16.53%
2017 -30.22%
2016 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.58 -11.06%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.10%
CH